Alwashmi M, Hawboldt J, Davis E, Marra C, Gamble J-M, Ashour WA. JMIR mHealth and uHealth. The effect of smartphone interventions on patients with chronic obstructive pulmonary disease exacerbations: A systematic review and meta-analysis [Internet]. 2016;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85019981382&partnerID=MN8TOARS

Amegadzie JE, Gorgui J, Acheampong L, Gamble J-M, Farrell J, Gao Z. Journal of Asthma. Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma–COPD overlap: a systematic review and meta-analysis [Internet]. 2021;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85075145584&partnerID=MN8TOARS

Hall JJ, Eurich DT, Nagy D, Tjosvold L, Gamble J-M. Journal of General Internal Medicine. Thiazide Diuretic–Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85081924061&partnerID=MN8TOARS

Gamble J-M. Journal of General Internal Medicine. Capsule Commentary on Franklin et al., Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85053375968&partnerID=MN8TOARS

Simpson SH, Gamble J-M, Mereu L, Chambers T. Journal of General Internal Medicine. Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: A meta-analysis [Internet]. 2011;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-80755153633&partnerID=MN8TOARS

Alkabbani W, Gamble J-M. Journal of Pharmaceutical Health Services Research. Trends in estimated total retail dispensed prescriptions of purported COVID-19 treatments and preventions in Canada [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85163707017&partnerID=MN8TOARS

Gamble J-M, Hoang H, Eurich DT, Jindal KK, Senior PA. Journal of Primary Care and Community Health. Patient-Level Evaluation of Community-Based, Multifactorial Intervention to Prevent Diabetic Nephropathy in Northern Alberta, Canada [Internet]. 2012;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84926525003&partnerID=MN8TOARS

Grandy CA, Donnan JR, Peddle JT, Romme K, Kim S, Gamble J-M. Journal of the American Medical Informatics Association. A systematic assessment of the availability and clinical drug information coverage of machine-readable clinical drug data sources for building knowledge translation products [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85055131397&partnerID=MN8TOARS

Gamble J-M, Chibrikov E, Twells LK, Midodzi WK, Young SW, MacDonald D, et al. The Lancet Diabetes and Endocrinology. Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study [Internet]. 2017;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85006721048&partnerID=MN8TOARS

Gamble J-M, Majumdar SR, Johnson JA, McAlister FA, Simpson SH, Eurich DT. Medical Care. Changes in thiazolidinedione use and outcomes following removal of a prior-authorization policy: Controlled time-series analysis [Internet]. 2014;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84890441981&partnerID=MN8TOARS

Gamble J-M, Butalia S. Medical Practice Variations. Medical Practice Variations in Diabetes Mellitus. 2016;

Gamble J-M, Thomas JM, Twells LK, Midodzi WK, Majumdar SR. Medicine (United States). Comparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy users [Internet]. 2016;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84978686237&partnerID=MN8TOARS

Alwashmi MF, Fitzpatrick B, Davis E, Gamble J-M, Farrell J, Hawboldt J. Perceptions of Health Care Providers Regarding a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: Qualitative Study. JMIR Mhealth Uhealth. 2019;7(6):e13950.

Gamble JM, Traynor RL, Gruzd A, Mai P, Dormuth CR, Sketris IS. Pharmacoepidemiology and Drug Safety. Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85044325731&partnerID=MN8TOARS

Gamble JM, Traynor RL, Gruzd A, Mai P, Dormuth CR, Sketris IS. Pharmacoepidemiology and Drug Safety. Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85044325731&partnerID=MN8TOARS

Gamble J-M, Johnson JA, Majumdar SR, McAlister FA, Simpson SH, Eurich DT. Pharmacoepidemiology and Drug Safety. Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure data [Internet]. 2013;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84877605478&partnerID=MN8TOARS

Asadi L, Eurich DT, Gamble J-M, Minhas-Sandhu JK, Marrie TJ, Majumdar SR. Respiratory Medicine. Guideline adherence and macrolides reduced mortality in outpatients with pneumonia [Internet]. 2012;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84855891949&partnerID=MN8TOARS

Amegadzie JE, Gamble J-M, Farrell J, Gao Z. Respiratory Research. Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85144299296&partnerID=MN8TOARS

Alkabbani W, Gamble J-M, Eurich DT, Minhas-Sandhu JK, Shah BR, Alsabbagh MWasem, et al. Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs. DIABETES & METABOLISM. 2022;48:101305.

Alkabbani W, Gamble JM, Eurich DT, Minhas-Sandu J, Shah BR, Alsabbagh W, et al. Risk of hospitalization and death associated with Sodium Glucose Cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs. Diabetes and Metabolism. 2021;